FDA approves linagliptin/metformin

Boehringer Ingelheim GmbH (Ingelheim, Germany) and partner Eli Lilly and Co. (NYSE:LLY) said FDA approved Jentadueto linagliptin/metformin to treat Type II diabetes. The partners plan to launch the pr...